2018
DOI: 10.15288/jsad.2018.79.182
|View full text |Cite
|
Sign up to set email alerts
|

Advancing Analytic Approaches to Address Key Questions in Mechanisms of Behavior Change Research

Abstract: Interest in studying mechanisms of behavior change (MOBCs) in substance use disorder (SUD) treatments has grown considerably in the past two decades. Much of this work has focused on identifying which variables statistically mediate the effect of SUD treatments on clinical outcomes. However, a fuller conceptualization of MOBCs will require greater understanding of questions that extend beyond traditional mediation analysis, including better understanding of when MOBCs change during treatment, when they are mos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
22
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 19 publications
(22 citation statements)
references
References 71 publications
0
22
0
Order By: Relevance
“…There is growing interest in more precisely delineating how and when key clinical improvements occur during AUD treatment (Hallgren et al, in press; Huebner & Tonigan, 2007; Longabaugh et al, 2005; Magill et al, 2015). The present study evaluated the timing and magnitude of change in daily craving and negative affect in relationship to the initiation of abstinence from alcohol in the context of a trial of prazosin treatment for AUD.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…There is growing interest in more precisely delineating how and when key clinical improvements occur during AUD treatment (Hallgren et al, in press; Huebner & Tonigan, 2007; Longabaugh et al, 2005; Magill et al, 2015). The present study evaluated the timing and magnitude of change in daily craving and negative affect in relationship to the initiation of abstinence from alcohol in the context of a trial of prazosin treatment for AUD.…”
Section: Discussionmentioning
confidence: 99%
“…The present study also extends this previous work by evaluating changes in daily negative affect (versus only craving) and by studying these changes in the context of a pharmacotherapy trial with no behavioral intervention (versus cognitive-behavioral treatments that include substantial education and psychotherapy around craving and negative affect). These findings could potentially help advance a greater understanding of the timing and magnitude of change in hypothesized mechanisms of behavioral change and key AUD treatment targets (Hallgren et al, in press), and may also help providers and patients better anticipate the expected timing and degree of change in the intensity of craving and negative affect, both over time and in relationship with initiating abstinence, providing evidence-based information that can support treatment goals and clinical decision-making.…”
Section: Introductionmentioning
confidence: 96%
See 1 more Smart Citation
“…Latent growth curve mediation models (LGCMM) have become more common in applied contexts to study whether some treatment variable is expected to affect an outcome via changes in some mediating process. Given the growing popularity of this model in the field (see Hallgren et al, 2018), it is critically important to check underlying assumptions to ensure valid results. One of these assumptions is an untestable assumption that there are not omitted confounders from the model.…”
Section: Conclusion and Summarymentioning
confidence: 99%
“…One important application of a multiple mediator model with two covarying mediators is the latent growth curve mediation model (LGCMM) with repeated measures/multilevel data, whereby some treatment variable is expected to affect an outcome via the change in some mediating process (Selig & Preacher, 2009; von Soest & Hagtvet, 2011). LGCMM is increasingly used to test hypothesized mechanisms of behavior change following treatments for psychological disorders (Hallgren, Wilson, & Witkiewitz, 2018). For example, as shown in Figure 1, in alcohol treatment one might hypothesize that an anti-craving medication (e.g., naltrexone) affects reductions in alcohol use via changes in craving over time.…”
mentioning
confidence: 99%